Announce Date | 05/02/2024 |
EPS Normalized Actual | $-0.12 (Beat by $0.69) |
EPS GAAP Actual | $-0.12 (Beat by $0.69) |
Revenue Actual | $0.155174B |
Revenue Surprise | Beat by $155.174M |
Announce Date | 07/01/2024 (Pre-Market) |
EPS Normalized Estimate | $0.43 |
EPS GAAP Estimate | $0.43 |
Revenue Estimate | $0.2208B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2025 | 1.06 | 16.71 | 1.06 | 1.06 | 1 |
Dec 2024 | 0 | INF | 0 | 0 | 19 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2022 (Mar 2022) | -1.62 | -1.62 | 0.155174B | 26.2% | 155.17M |
FQ4 2021 (Dec 2021) | -3.3563 | -3.3563 | 0.148B | 23.67% | 148M |
FQ3 2021 (Sep 2021) | -2.05 | -2.05 | 0.140984B | 26.51% | 140.98M |
FQ2 2021 (Jun 2021) | -3.87 | -3.87 | 0.13742B | 17.57% | 137.42M |
FQ1 2021 (Mar 2021) | -5.28 | -5.28 | 0.114517B | -59.48% | 114.52M |
FQ4 2020 (Dec 2020) | -5.85 | -5.85 | 0.112963B | -76.85% | 112.96M |
FQ3 2020 (Sep 2020) | -3.8 | -3.8 | 0.103606B | -130.94% | 103.61M |
FQ2 2020 (Jun 2020) | -1 | -1 | 0.113275B | -116.86% | 113.28M |
FQ4 Announce Date
07/01/2024 (Pre-Market)
Consensus EPS Estimates
0.43
Consensus Revenue Estimates
0.2208B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.35 | -- | 0.34597 | 0.35403 | 0 |
FQ3 2025 (Jul 2025) | 0.41 | -- | 0.40528 | 0.41472 | 0 |
FQ2 2025 (Jun 2025) | 0.41 | -- | 0.41 | 0.41 | 0 |
FQ1 2025 (Mar 2025) | 0.21 | -- | 0.21 | 0.21 | 0 |
FQ4 2024 (Oct 2024) | 0.535 | -- | 0.52884 | 0.54116 | 1 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2025 (Oct 2025) | 0.23B | -- | 0.23B | 0.23B | 0 |
FQ3 2025 (Jul 2025) | 0.23B | -- | 0.23B | 0.24B | 0 |
FQ2 2025 (Jun 2025) | 0.23B | -- | 0.23B | 0.23B | 0 |
FQ1 2025 (Mar 2025) | 0.22B | -- | 0.22B | 0.22B | 0 |
FQ4 2024 (Oct 2024) | 0.23B | -- | 0.22B | 0.23B | 1 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
0
EPS # of Misses
8
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | -1.62 | -1.62 | 100% | |
FQ4 2021 (Dec 2021) | -3.3563 | -3.3563 | 100% | |
FQ3 2021 (Sep 2021) | -2.05 | -2.05 | 100% | |
FQ2 2021 (Jun 2021) | -3.87 | -3.87 | 100% | |
FQ1 2021 (Mar 2021) | -5.28 | -5.28 | 100% | |
FQ4 2020 (Dec 2020) | -5.85 | -5.85 | 100% | |
FQ3 2020 (Sep 2020) | -3.8 | -3.8 | 100% | |
FQ2 2020 (Jun 2020) | -1 | -1 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2022 (Mar 2022) | $0B | $0.16B | $155.17M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.15B | $148M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.14B | $140.98M | 100% |
FQ2 2021 (Jun 2021) | $0B | $0.14B | $137.42M | 100% |
FQ1 2021 (Mar 2021) | $0B | $0.11B | $114.52M | 100% |
FQ4 2020 (Dec 2020) | $0B | $0.11B | $112.96M | 100% |
FQ3 2020 (Sep 2020) | $0B | $0.1B | $103.61M | 100% |
FQ2 2020 (Jun 2020) | $0B | $0.11B | $113.28M | 100% |